biotech · Dystrophic Epidermolysis Bullosa · Autosomal Recessive Ichthyosis · KRYS
Krystal Biotech Netherlands
Krystal Biotech Netherlands B.V.
Krystal Biotech Netherlands trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
2100 Wharton Street, Suite 701, Pittsburgh, PA 15203, US HQ
2016 Founded
306 Employees
Public company Type
KRYS · NYSE Ticker
Company details
- Status
- Public
- HQ
- 2100 Wharton Street, Suite 701, Pittsburgh, PA 15203, US
- Founded
- 2016
- Employees
- 306
- Programs
- 14
- Drugs
- 7
- Patents
- 14
Krystal Biotech Netherlands clinical trials
Registry index of 16 ClinicalTrials.gov studies linked to Krystal Biotech Netherlands programs — each row shows trial ID, program name, phase, status, and indication.
Krystal Biotech Netherlands trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Krystal Biotech Netherlands.
-
Topical Beremagene Geperpavec — Phase 3
Clinical update -
Open Label Topical Beremagene Geperpavec (B-VEC) — Phase 3
Clinical update -
Mebendazole — Phase 2
Clinical update -
KB803 — Phase 3
Clinical update -
KB408 (Nebulization) — Phase 1
Clinical update -
KB105 — Phase 2
Clinical update -
KB105 — Phase 2
Clinical update -
KB304 — Phase 2
Clinical update